The potential health benefits of haskap (Lonicera caerulea L.): Role of cyanidin-3-O-glucoside

被引:116
作者
Rupasinghe, H. P. Vasantha [1 ,2 ]
Arumuggam, Niroshaathevi [1 ]
Amararathna, Madumani [1 ,2 ]
De Silva, A. B. K. H. [1 ]
机构
[1] Dalhousie Univ, Fac Agr, Dept Plant Food & Environm Sci, Truro, NS, Canada
[2] Dalhousie Univ, Fac Med, Dept Pathol, Halifax, NS, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
Antioxidants; Anthocyanin; Polyphenols; Oxidative stress; Chronic diseases; Physiological function; ACTIVATED PROTEIN-KINASE; EXTRACT AMELIORATES HYPERGLYCEMIA; NITRIC-OXIDE SYNTHASE; UVA-INDUCED DAMAGE; BLUE HONEYSUCKLE; IN-VITRO; CYANIDIN; 3-GLUCOSIDE; ANTIOXIDANT CAPACITY; INSULIN SENSITIVITY; BIOACTIVE COMPOUNDS;
D O I
10.1016/j.jff.2018.02.023
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Haskap (Lonicera caerulea L.), an emerging commercial fruit crop in North America, has been known for its medicinal benefits amongst the people of Russia, Japan, and Northeastern China for centuries. The vitamin C content in haskap berries, ranging between 29 and 187 mg/100 g, is significantly higher than in other vitamin C-rich sources such as oranges, strawberries, and raspberries. Cyanidin-3-O-glucoside (C3G) is the major anthocyanin present in haskap comprising about 79-92% of its total anthocyanin content and over 60% of the total polyphenols. Considerable evidence shows significant antioxidant, cardio-protective, anti-inflammatory, neuroprotective, anticancer, and anti-diabetic properties of C3G-rich haskap preparations and C3G alone both in vitro and in vivo. This review broadly discusses the in vitro and pre-clinical significance of haskap-mediated cytoprotection and disease prevention; thereby, we strongly suggest further exploration of C3G-rich haskap preparations as potential functional food, dietary antioxidant supplements as well as natural health products targeting specific chronic and metabolic diseases.
引用
收藏
页码:24 / 39
页数:16
相关论文
共 194 条
[1]   Inhibitory Activities of Cyanidin and Its Glycosides and Synergistic Effect with Acarbose against Intestinal α-Glucosidase and Pancreatic α-Amylase [J].
Akkarachiyasit, Sarinya ;
Charoenlertkul, Piyawan ;
Yibchok-anun, Sirintorn ;
Adisakwattana, Sirichai .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2010, 11 (09) :3387-3396
[2]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]  
2-S
[4]   Anti-cancer evaluation of various solvent extracts of blue honeysuckle berry (Lonicera caerulea L.) against prostate cancer cells [J].
Ali, Syed M. ;
Ourth, Alex ;
Che, Chun-Tao ;
Wang, Mian-Ying ;
Munirathinam, Gnanasekar .
CANCER RESEARCH, 2017, 77
[5]   Cyanidin-3-O-β-glucopyranoside protects myocardium and erythrocytes from oxygen radical-mediated damages [J].
Amorini, AM ;
Lazzarino, G ;
Galvano, F ;
Fazzina, G ;
Tavazzi, B ;
Galvano, G .
FREE RADICAL RESEARCH, 2003, 37 (04) :453-460
[6]  
Anikina E. V., 1988, Chemistry of Natural Compounds, V24, P512, DOI [10.1007/BF00598552, DOI 10.1007/BF00598552]
[7]  
[Anonymous], 1894, Journalof the Chemical Society, Transactions, DOI [10.1039/ct8946500899, DOI 10.1039/CT8946500899]
[8]   A Review: Phytochemicals Targeting JAK/STAT Signaling and IDO Expression in Cancer [J].
Arumuggam, Niroshaathevi ;
Bhowmick, Neil A. ;
Rupasinghe, H. P. Vasantha .
PHYTOTHERAPY RESEARCH, 2015, 29 (06) :805-817
[9]   Survey of bioactive components in Western Canadian berries [J].
Bakowska-Barczak, Anna M. ;
Marianchuk, Myles ;
Kolodziejczyk, Paul .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2007, 85 (11) :1139-1152
[10]  
Baron AD, 1998, DIABETES RES CLIN PR, V40, pS51